Прекращено
Фаза II
Россия
ARC1779-003 · Archemix Corp.
A Phase 2 Study of an Aptameric Von Willebrand Factor Antagonist, ARC1779, in Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention